Please login to the form below

Not currently logged in
Email:
Password:

ASCO

This page shows the latest ASCO news and features for those working in and with pharma, biotech and healthcare.

Roche keeps Venclexta train rolling with new leukaemia filing

Roche keeps Venclexta train rolling with new leukaemia filing

Data reported at this year’s American Society of Clinical Oncology (ASCO) meeting showed overall responses rates above 80%, with complete responses seen in upwards of 60% of patients – a step

Latest news

More from news
Approximately 22 fully matching, plus 102 partially matching documents found.

Latest Intelligence

  • No incentive for a cure No incentive for a cure

    The systems we have -. from the ICER Value Assessment Framework to the ASCO Value Framework - are often at odds with each other, and none of them wholly addresses all the attributes

  • Avoiding data pitfalls in clinical research Avoiding data pitfalls in clinical research

    Meeting of the American Society of Clinical Oncology (ASCO). ... The pilot was successful enough to be accepted for presentation at the ASCO’s Annual Meeting, the largest academic cancer conference in the world.

  • Are we #winning? Are we #winning?

    We’ve seen multiple online ‘TV’channels launch from medical societies and congress; some (eg ASCO) have commoditised their assets, and - for example, with Novartis’VivindaTV.com - pharma is now competing

  • Reactivating drug research programmes Reactivating drug research programmes

    Further evidencing the efficacy of precision drug treatments, a recent study by ASCO, which was carried out with 13, 000 patients in 346 trials, has shown that patients experienced a significantly

  • Managed Access Programmes: a powerful source of real-world insight Managed Access Programmes: a powerful source of real-world insight

    access program (EAP), ASCO 2016.

More from intelligence
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest from PMHub

  • How did pharma use Twitter at #ASCO16?

    How did pharma use Twitter at #ASCO16? Each year, ASCO’ s Annual Meeting brings together 30, 000 oncology professionals from around the world, here we explore the #ASCO16 hashtag and how ... ASCO’ s Annual Meeting has led the way in terms of social

  • ASCO 2015: What you missed in Chicago

    Three monoclonal antibodies were presented on the last day of ASCO - two in multiple myeloma and one in amyloidosis. ... ASCO 15: Highlighting innovation and raising key questions. Amgen and AstraZeneca had excellent booths that were extremely

  • Ashfield

    Each year, ASCO’ s Annual Meeting brings together 30, 000 oncology professionals from around the world, here we explore the #ASCO16 hashtag and how pharma utilised the channel during this

  • Ashfield

    Each year, ASCO’ s Annual Meeting brings together 30, 000 oncology professionals from around the world, here we explore the #ASCO16 hashtag and how pharma utilised the channel during this

  • The heart of the matter: Part Two

    Meanwhile, among the mainstream social channels. Twitter in particular clearly resonates as a tool within the medical community at congresses - this year’ s ASCO meeting even saw the American Society of

More from PMHub
Approximately 2 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics